These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15589603)

  • 41. Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy.
    Wyman K; Atkins MB; Prieto V; Eton O; McDermott DF; Hubbard F; Byrnes C; Sanders K; Sosman JA
    Cancer; 2006 May; 106(9):2005-11. PubMed ID: 16565971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
    Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of c-kit in North African nasopharyngeal carcinomas: correlation with age and LMP1].
    Charfi S; Khabir A; Ayadi L; Mseddi M; Makni H; Gorbel A; Daoud J; Frikha M; Jlidi R; Busson P; Boudawara TS
    Cancer Radiother; 2007 Sep; 11(5):247-51. PubMed ID: 17689127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
    Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
    Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behavior of uterine carcinosarcoma.
    Yoshida Y; Kurokawa T; Fukuno N; Nishikawa Y; Kamitani N; Kotsuji F
    Hum Pathol; 2000 Dec; 31(12):1448-54. PubMed ID: 11150369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
    Zhao P; Hou N; Shao Y; Li XH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endometrial carcinoma recurring as carcinosarcoma: report of two cases.
    Ferrandina G; Zannoni GF; Martinelli E; Vellone V; Prisco MG; Scambia G
    Pathol Res Pract; 2007; 203(9):677-81. PubMed ID: 17646054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.
    Diniz G; Aktas S; Ortac R; Tunakan M; Unlu I; Vergin C
    Pathol Res Pract; 2006; 202(9):671-7. PubMed ID: 16860492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
    Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A
    J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-kit expression in adenoid cystic carcinoma does not have an impact on local or distant tumor recurrence.
    Aslan DL; Oprea GM; Jagush SM; Gulbahce HE; Adams GL; Gaffney PM; Savik K; Pambuccian SE
    Head Neck; 2005 Dec; 27(12):1028-34. PubMed ID: 16240323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation.
    Hirano K; Shishido-Hara Y; Kitazawa A; Kojima K; Sumiishi A; Umino M; Kikuchi F; Sakamoto A; Fujioka Y; Kamma H
    Pathol Res Pract; 2008; 204(11):799-807. PubMed ID: 18602222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kit expression in male germ cell tumors.
    Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos T; Pectasides D
    Anticancer Res; 2007; 27(3B):1685-8. PubMed ID: 17595797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
    Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC
    Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
    Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD117 (c-kit) expression in human hepatocellular carcinoma.
    Becker G; Schmitt-Graeff A; Ertelt V; Blum HE; Allgaier HP
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):204-8. PubMed ID: 17359908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endometrial stromal sarcomas with extensive endometrioid glandular differentiation: report of a series with emphasis on the potential for misdiagnosis and discussion of the differential diagnosis.
    McCluggage WG; Ganesan R; Herrington CS
    Histopathology; 2009 Feb; 54(3):365-73. PubMed ID: 19236513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma. Is there any role in disease process?
    Kara IO; Gonlusen G; Sahin B; Ergin M; Erdogan S
    Saudi Med J; 2005 Aug; 26(8):1190-6. PubMed ID: 16127511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.